f i , For QoL measures, statistical significance was met with group 4 for ADCS-ADL at 39 weeks (group 4, P = 0.04; n = 10) compared to placebo ( n = 10) ( f ), while group 2 ( P = 0.228, n = 12) and group 3 ( P = 0.103, n = 11) showed numerical improvement relative to placebo ( n = 10). Numerical improvement was observed in group 4 at 39 weeks for QoL-AD (caregiver) ( P = 0.142, n = 10) compared to placebo ( n = 10) ( g ), but no improvement was found in QoL-AD (study participant) scores (combined groups 24, P = 0.797, n = 33) compared to placebo ( n = 10) ( h ) while a numeric trend towards improvement was found in group 4 ( P = 0.275, n = 10) at 39 weeks for ADRQL scores compared to placebo ( n = 10) ( i ). Error bars represent s.e.m.
